Huber Needles Market Outlook:
Huber Needles Market size was over USD 53.9 million in 2025 and is anticipated to cross USD 82.91 million by 2035, growing at more than 4.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of huber needles is assessed at USD 56.03 million.
The market growth is attributed to worldwide increasing prevalence of chronic renal diseases. For instance, chronic kidney disease is a degenerative disorder that affects more than 12% of the global population, that represents more than 900 million people.
Huber needles are hollow needles that have slant tip to make it easy to go throw skin. These needles are primarily used for recurrent access to veins for blood extraction and the infusion of blood products, medicine, and nutritional solutions in combination with a point implanted in the body of a persistently ill patient. Increasing use of huber needles for the treatment of hepatitis and HIV is fueling the huber needles market growth. As per the statistics provided by the World Health Organization (WHO), more than 350 million people worldwide are still surviving with the risk of hepatitis B or C infection.
Key Huber Needles Market Insights Summary:
Regional Highlights:
- North America is anticipated to capture a 30.2% share by 2035, driven by significant propagation in chemotherapy and dialysis processes amid the rising prevalence of lifestyle diseases and chronic disorders
Segment Insights:
- The blood transfusion segment in the huber needles market is projected to account for the largest share by 2035, propelled by the staggering increase in blood transfusion throughout the world
Key Growth Trends:
- Rising Prevalence of Needle Stick Injuries in Healthcare Workers
- Global Surge in HIV Prevalence
Major Challenges:
- High Cost Associated with The Manufacturing of Huber Needle Product
- Lack of Technological Advancement
Key Players: Kawasaki Heavy Industries, Ltd., Seiko Epson Corporation, Rockwell Automation, Inc., ABB Ltd, Switzerland, Denso Corporation, Comau S.p.A., Fanuc Corporation, Yaskawa Electric Corporation, Blackbird GmbH, Nachi Fujikoshi Corp.
Global Huber Needles Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 53.9 million
- 2026 Market Size: USD 56.03 million
- Projected Market Size: USD 82.91 million by 2035
- Growth Forecasts: 4.4% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (30.2% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, China, United Kingdom
- Emerging Countries: China, India, Japan, South Korea, Brazil
Last updated on : 25 February, 2026
Huber Needles Market - Growth Drivers and Challenges
Growth Drivers
-
Rising Prevalence of Needle Stick Injuries in Healthcare Workers – Needle stick injuries are injuries caused by needles that pierce the skin by accident. Needle stick injuries are a risk for everyone who works with intravenous syringes or other needle-related equipment. These injuries most commonly occur when persons, such as nursing students, use, dismantle, or discard of needles. Therefore, surging cases of needle stick injuries in healthcare workers are lifting up the huber needles market growth. For instance, presently, in the United States alone, over 5 million healthcare professionals are at risk of exposure to blood borne infections caused by needle stick or other sharp objects injuries.
- Global Surge in HIV Prevalence – According to the World Health Organization data, an anticipated 1.5 million (UI 1.0 to 2.0 million) people were infected with HIV for the first time. This carried the worldwide HIV population to 38.4 million people by 2021.
- Worldwide Growing Occurrence of Cancer - According to World Health Organization (WHO) figures, approximately 10 million people died from cancer worldwide in 2020.
- Increasing Ratio of Obesity in People Across the Globe – For instance, more than 2 billion people globally, including 700 million adults, 380 million teenagers, and 45 million children, are affected by obesity.
- Worldwide Spike in Healthcare Expenditure - According to the World Bank statistics, worldwide healthcare expenditure accelerated by 9.83% in 2019.
Challenges
- High Cost Associated with The Manufacturing of Huber Needle Product
- Lack of Technological Advancement
- High Risk of Contamination
Huber Needles Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
4.4% |
|
Base Year Market Size (2025) |
USD 53.9 million |
|
Forecast Year Market Size (2035) |
USD 82.91 million |
|
Regional Scope |
|
Huber Needles Market Segmentation:
Application Segment Analysis
The blood transfusion segment is poised to dominate largest huber needles market share by the end of 2035, on the back of the staggering increase in blood transfusion throughout the world. Based on the data released by the World Health Organization, worldwide, nearly 118.54 million blood transfusions are collected.
Our in-depth analysis of the global huber needles market includes the following segments:
|
By Product Type |
|
|
By Application |
|
|
By End-User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Huber Needles Market - Regional Analysis
North America is projected to hold largest huber needles market share of 30.2% by the end of 2035, backed by significant propagation in chemotherapy and dialysis processes on account of major surge in lifestyle diseases, such as, diabetes, along with increasing count of various chronic disorders. For instance, approximately 790,000 individuals in the United States developed ESKD, also widely recognized as an end-stage renal disease (ESRD), in 2020, with 75% were receiving dialysis and 30% receiving a kidney transplant.
Huber Needles Market Players:
- B. Braun Medical Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ICU Medical, Inc.
- Baxter International, Inc.
- Nipro Medical Corporation
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Vygon SAS
- EXELINT International, Co.
- Medtronic
- Terumo Corporation
Recent Developments
-
Becton, Dickinson and Company introduced a new generation of prefillable syringes (PFS) that sets a new benchmark for vaccine PFS performance. In collaboration with leading pharmaceutical companies, the new BD Effivax Glass Prefillable Syringe has been designed to meet the complex and evolving needs of vaccine manufacturers.
-
CU Medical, Inc., has acquired the Smiths Medical from Smiths Group plc., who is a leading provider of syringe and ambulatory infusion devices, vascular access, and vital care products.
- Report ID: 319
- Published Date: Feb 25, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Huber Needles Market Report Scope
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
